These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 20575683)

  • 1. Cardioprotective effect of periodontal therapy in metabolic syndrome: a pilot study in Indian subjects.
    Acharya A; Bhavsar N; Jadav B; Parikh H
    Metab Syndr Relat Disord; 2010 Aug; 8(4):335-41. PubMed ID: 20575683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of metabolic syndrome and periodontal disease in an Indian population.
    Patel SP; Kalra N; Pradeep AR; Martande SS; Naik SB; Raju AP; Singh P
    J Int Acad Periodontol; 2014 Oct; 16(4):98-102. PubMed ID: 25654962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic syndrome and periodontal diseases.
    Dumitrescu AL; Zetu L; Teslaru S
    Rom J Intern Med; 2008; 46(3):207-12. PubMed ID: 19366079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe periodontitis is associated with systemic inflammation and a dysmetabolic status: a case-control study.
    Nibali L; D'Aiuto F; Griffiths G; Patel K; Suvan J; Tonetti MS
    J Clin Periodontol; 2007 Nov; 34(11):931-7. PubMed ID: 17877746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Periodontal infections cause changes in traditional and novel cardiovascular risk factors: results from a randomized controlled clinical trial.
    D'Aiuto F; Parkar M; Nibali L; Suvan J; Lessem J; Tonetti MS
    Am Heart J; 2006 May; 151(5):977-84. PubMed ID: 16644317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of leukocyte count and hsCRP with metabolic abnormalities in subjects with normal glucose tolerance (CURES - 64).
    Gokulakrishnan K; Deepa R; Sampathkumar R; Balasubramanyam M; Mohan V
    J Assoc Physicians India; 2009 Jan; 57():27-32. PubMed ID: 19753755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between periodontitis and systemic inflammation in patients with end-stage renal disease.
    Nadeem M; Stephen L; Schubert C; Davids MR
    SADJ; 2009 Nov; 64(10):470-3. PubMed ID: 20306866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Markers of inflammation and prevalence of vascular disease in patients with metabolic syndrome.
    Novo G; Corrado E; Muratori I; Tantillo R; Bellia A; Galluzzo A; Vitale G; Novo S
    Int Angiol; 2007 Dec; 26(4):312-7. PubMed ID: 18091698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum C3 is a stronger inflammatory marker of insulin resistance than C-reactive protein, leukocyte count, and erythrocyte sedimentation rate: comparison study in an elderly population.
    Muscari A; Antonelli S; Bianchi G; Cavrini G; Dapporto S; Ligabue A; Ludovico C; Magalotti D; Poggiopollini G; Zoli M;
    Diabetes Care; 2007 Sep; 30(9):2362-8. PubMed ID: 17595349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic syndrome, insulin resistance, and periodontitis: a cross-sectional study in a middle-aged French population.
    Benguigui C; Bongard V; Ruidavets JB; Chamontin B; Sixou M; Ferrières J; Amar J
    J Clin Periodontol; 2010 Jul; 37(7):601-8. PubMed ID: 20492076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Waist circumference adds to the variance in plasma C-reactive protein levels in elderly patients with metabolic syndrome.
    Dupuy AM; Jaussent I; Lacroux A; Durant R; Cristol JP; Delcourt C
    Gerontology; 2007; 53(6):329-39. PubMed ID: 17551260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Periodontal therapy: a novel non-drug-induced experimental model to study human inflammation.
    D'Aiuto F; Nibali L; Mohamed-Ali V; Vallance P; Tonetti MS
    J Periodontal Res; 2004 Oct; 39(5):294-9. PubMed ID: 15324349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of periodontal status in subjects with hyperlipidemia.
    Awartani F; Atassi F
    J Contemp Dent Pract; 2010 Mar; 11(2):033-40. PubMed ID: 20228985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Periodontal disease is associated with metabolic syndrome in hemodialysis patients.
    Chen LP; Hsu SP; Peng YS; Chiang CK; Hung KY
    Nephrol Dial Transplant; 2011 Dec; 26(12):4068-73. PubMed ID: 21602185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Periodontal health improves systemic inflammatory and haemostatic status in subjects with coronary heart disease.
    Montebugnoli L; Servidio D; Miaton RA; Prati C; Tricoci P; Melloni C; Melandri G
    J Clin Periodontol; 2005 Feb; 32(2):188-92. PubMed ID: 15691350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of lowering uric acid levels using allopurinol on markers of metabolic syndrome in end-stage renal disease patients: a pilot study.
    Shelmadine B; Bowden RG; Wilson RL; Beavers D; Hartman J
    Anadolu Kardiyol Derg; 2009 Oct; 9(5):385-9. PubMed ID: 19819789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic syndrome, C-reactive protein, and chronic kidney disease in nondiabetic, nonhypertensive adults.
    Lee JE; Choi SY; Huh W; Kim YG; Kim DJ; Oh HY
    Am J Hypertens; 2007 Nov; 20(11):1189-94. PubMed ID: 17954366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial.
    Stender S; Schuster H; Barter P; Watkins C; Kallend D;
    Diabetes Obes Metab; 2005 Jul; 7(4):430-8. PubMed ID: 15955130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-sensitivity serum C-reactive protein levels in subjects with or without myocardial infarction or periodontitis.
    Persson GR; Pettersson T; Ohlsson O; Renvert S
    J Clin Periodontol; 2005 Mar; 32(3):219-24. PubMed ID: 15766362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High serum high-sensitivity C-reactive protein concentrations are associated with relative cardiac sympathetic overactivity during the early morning period in type 2 diabetic patients with metabolic syndrome.
    Aso Y; Wakabayashi S; Nakano T; Yamamoto R; Takebayashi K; Inukai T
    Metabolism; 2006 Aug; 55(8):1014-21. PubMed ID: 16839835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.